GlassScriptPhysician profile
Jason F Harrison
NPI 1245467604
$1,156.10
in general payments reported to CMS, 2019-2025
23 companies · $22.27 in 2025
The $22.27 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $361 · 2020: $175 · 2021: $170 · 2022: $126 · 2023: $224 · 2024: $78.71 · 2025: $22.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $198.92 | 2019-2024 | Acis Proti 360 Hl, Skyline |
| Centinel Spine, LLC | $112.60 | 2023 | Prodisc L |
| Ucb, INC. | $90.23 | 2019-2023 | Briviact |
| Abbott Laboratories | $76.55 | 2022 | |
| Merz North America, INC. | $72.99 | 2019-2020 | |
| Abbvie INC. | $66.37 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $63.01 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $61.74 | 2019-2020 | |
| Medtronic, INC. | $49.89 | 2024-2025 | Unid_pass |
| Biogen, INC. | $48.71 | 2022-2023 | Vumerity, Avonex, Tysabri |
| Bausch Health US, LLC | $46.23 | 2019 | |
| Acorda Therapeutics, INC | $44.48 | 2019 | |
| Amgen INC. | $38.01 | 2019-2023 | Aimovig |
| Greenwich Biosciences, INC. | $35.67 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $25.54 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $24.22 | 2020 | |
| Corium, LLC | $20.31 | 2023 | Adlarity |
| Neurocrine Biosciences, INC. | $15.63 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.06 | 2021 | |
| Si-Bone, INC. | $13.89 | 2023 | |
| Arbor Pharmaceuticals, INC. | $12.78 | 2020 | |
| Novartis Pharmaceuticals Corporation | $12.30 | 2019 | |
| Kyowa Kirin, INC. | $10.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.